Soleus Capital Management’s Inhibikase Therapeutics IKT Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$12.3M	Hold	6,325,000	–	–	0.82%	33
2025 Q1	$13.9M	Hold	6,325,000	–	–	1%	28
2024 Q4	$20.6M	Buy	+6,325,000	New	+$20.6M	1.29%	22